These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10402946)

  • 1. [Treatment of Crohn disease with anti-tumor necrosis factor alpha].
    Rasmussen SN; Petersen JA
    Ugeskr Laeger; 1999 Jun; 161(26):4026-9. PubMed ID: 10402946
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in Crohn's disease.
    Rutgeerts PJ
    Rev Gastroenterol Disord; 2004; 4 Suppl 3():S1-2. PubMed ID: 15580147
    [No Abstract]   [Full Text] [Related]  

  • 3. [When should anti-TNF-alpha treatment in Crohn disease be terminated?].
    Moum B
    Tidsskr Nor Laegeforen; 2010 Mar; 130(5):474. PubMed ID: 20224609
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti tumor necrosis factor alpha antibody: infliximab].
    Arimitsu S; Ito H
    Nihon Rinsho; 2012 Feb; 70 Suppl 1():329-32. PubMed ID: 23126112
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological compounds in the treatment of Crohn's disease].
    Dinari G
    Harefuah; 2001 Apr; 140(4):316-8. PubMed ID: 11303396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Practice guidelines in gastroenterology. Use of anti-TNF agents in inflammatory bowel disease. European guide 2001-2003].
    Rom J Gastroenterol; 2002 Mar; 11(1):68-71. PubMed ID: 12219731
    [No Abstract]   [Full Text] [Related]  

  • 7. Algorithm for the treatment of Crohn's disease: incorporation of emerging therapies.
    Souney PF
    Am J Gastroenterol; 2000 Sep; 95(9):2381-3. PubMed ID: 11007248
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF.
    Holtmann MH; Galle PR; Neurath MF
    Am J Gastroenterol; 2003 Feb; 98(2):504-5. PubMed ID: 12591081
    [No Abstract]   [Full Text] [Related]  

  • 9. Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg?
    Hollander D
    Am J Gastroenterol; 2002 Aug; 97(8):1867-8. PubMed ID: 12190145
    [No Abstract]   [Full Text] [Related]  

  • 10. [What can be expected from biological therapies for Crohn's disease?].
    Lemann M
    Gastroenterol Clin Biol; 2001 Nov; 25(11):945-7. PubMed ID: 11845043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-TNF antibodies in the treatment of intestinal inflammatory disease].
    Hinojosa J
    Gastroenterol Hepatol; 2000 May; 23(5):250-7. PubMed ID: 10902280
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases].
    Wittig BM; Zeitz M
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S52-8. PubMed ID: 11450615
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical effectiveness of short-term administration of monoclonal antibody cA2 against tumor necrosis factor alpha in Crohn disease].
    Schreiber S; Koop I
    Z Gastroenterol; 1998 Apr; 36(4):349-51. PubMed ID: 9612932
    [No Abstract]   [Full Text] [Related]  

  • 14. Crohn's disease in common variable immunodeficiency: treatment with antitumor necrosis factor alpha.
    Nos P; Bastida G; Beltran B; Aguas M; Ponce J
    Am J Gastroenterol; 2006 Sep; 101(9):2165-6. PubMed ID: 16968516
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumour necrosis factor alpha antibody affects gastrin release in Crohn disease.
    Hopman WP; de Jong DJ; Naber AH; Jansen JB
    Scand J Gastroenterol; 2003 May; 38(5):522-5. PubMed ID: 12795463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remicade: six years of experience in immune-mediated inflammatory disorders].
    Guillevin L
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 2):1S5-7. PubMed ID: 16967602
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of vulval Crohn's disease with infliximab.
    Preston PW; Hudson N; Lewis FM
    Clin Exp Dermatol; 2006 May; 31(3):378-80. PubMed ID: 16681581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective TNF-alpha inhibition in Crohn disease. Emergency help in problem cases].
    MMW Fortschr Med; 2001 May; 143(18):52. PubMed ID: 11387713
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
    Tan MH; Gordon M; Lebwohl O; George J; Lebwohl MG
    Arch Dermatol; 2001 Jul; 137(7):930-3. PubMed ID: 11453813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.